Federation des caisses Desjardins du Quebec’s Vir Biotechnology VIR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.11K	Sell	600 -500	-45%	-$4.76K	﹤0.01%	2548
2026 Q1	$9.86K	Buy	1,100 +1,000	+1,000%	+$7.97K	﹤0.01%	2328
2025 Q4	$603	Hold	100	–	–	﹤0.01%	2721
2025 Q3	$571	Hold	100	–	–	﹤0.01%	2720
2025 Q2	$504	Hold	100	–	–	﹤0.01%	2576
2025 Q1	$648	Hold	100	–	–	﹤0.01%	2465
2024 Q4	$734	Hold	100	–	–	﹤0.01%	2354
2024 Q3	$749	Sell	100 -150	-60%	-$1.3K	﹤0.01%	2349
2024 Q2	$2.23K	Hold	250	–	–	﹤0.01%	2100
2024 Q1	$2.53K	Hold	250	–	–	﹤0.01%	2084
2023 Q4	$2.52K	Sell	250 -100	-29%	-$914	﹤0.01%	2037
2023 Q3	$3.28K	Hold	350	–	–	﹤0.01%	2004
2023 Q2	$8.59K	Hold	350	–	–	﹤0.01%	1803
2023 Q1	$8.14K	Hold	350	–	–	﹤0.01%	1813
2022 Q4	$8.86K	Hold	350	–	–	﹤0.01%	1906
2022 Q3	$6.75K	Hold	350	–	–	﹤0.01%	2009
2022 Q2	$8.91K	Hold	350	–	–	﹤0.01%	1990
2022 Q1	$9K	Hold	350	–	–	﹤0.01%	2053
2021 Q4	$14.7K	Buy	350 +150	+75%	+$5.88K	﹤0.01%	1928
2021 Q3	$8.7K	Hold	200	–	–	﹤0.01%	2087
2021 Q2	$9.46K	Hold	200	–	–	﹤0.01%	2068
2021 Q1	$10.3K	Hold	200	–	–	﹤0.01%	1995
2020 Q4	$5.36K	Hold	200	–	–	﹤0.01%	2051
2020 Q3	$6.87K	Hold	200	–	–	﹤0.01%	1781
2020 Q2	$8.19K	Buy	+200	New	+$6.71K	﹤0.01%	1699

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's VIR Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Vir Biotechnology (VIR) stake by 45% in Q2 2026, selling an estimated $4.76K and leaving 600 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

Federation des caisses Desjardins du Quebec first reported a position in VIR in Q2 2020 and has held it in 25 quarters since. The position peaked at $14.7K in Q4 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Federation des caisses Desjardins du Quebec held 600 shares of Vir Biotechnology worth $6.11K as of Q2 2026.
Federation des caisses Desjardins du Quebec sold 500 Vir Biotechnology shares in Q2 2026, an estimated $4.76K.
Vir Biotechnology made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2548 holding.
Federation des caisses Desjardins du Quebec first reported a position in Vir Biotechnology in Q2 2020 and has held it in 25 quarters since.
Federation des caisses Desjardins du Quebec's Vir Biotechnology position peaked at $14.7K in Q4 2021.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.